← Back to home

UNTREATED B-CHRONIC LYMPHOCYTIC LEUKEMIA OR DIFFUSE LARGE B CELLS LYMPHOMA PATIENTS

Clinical trials for UNTREATED B-CHRONIC LYMPHOCYTIC LEUKEMIA OR DIFFUSE LARGE B CELLS LYMPHOMA PATIENTS explained in plain language.

Never miss a new study

Get alerted when new UNTREATED B-CHRONIC LYMPHOCYTIC LEUKEMIA OR DIFFUSE LARGE B CELLS LYMPHOMA PATIENTS trials appear

Sign up with your email to follow new studies for UNTREATED B-CHRONIC LYMPHOCYTIC LEUKEMIA OR DIFFUSE LARGE B CELLS LYMPHOMA PATIENTS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New PET tracer could sharpen detection of hard-to-see lymphomas

Diagnosis Completed

This early-phase study tested a new radioactive tracer, [18F]-Fludarabine, in 10 adults with untreated chronic lymphocytic leukemia or diffuse large B-cell lymphoma. The goal was to see how the tracer spreads in the body and how well it highlights cancer cells compared to standar…

Matched conditions: UNTREATED B-CHRONIC LYMPHOCYTIC LEUKEMIA OR DIFFUSE LARGE B CELLS LYMPHOMA PATIENTS

Phase: PHASE1 • Sponsor: University Hospital, Caen • Aim: Diagnosis

Last updated May 11, 2026 20:38 UTC

UNTREATED B-CHRONIC LYMPHOCYTIC LEUKEMIA OR DIFFUSE LARGE B CELLS LYMPHOMA PATIENTS

Get alerted when new UNTREATED B-CHRONIC LYMPHOCYTIC LEUKEMIA OR DIFFUSE LARGE B CELLS LYMPHOMA PATIENTS trials appear

New PET tracer could sharpen detection of hard-to-see lymphomas